News
We’re investing a further £1.5million to advance pioneering drug discovery work to develop new molecules that can both improve symptoms and slow progression.
European study suggests that smoking has a protective role to reduce the risk of developing Parkinson's.
Scientists have identified a key molecule - called USP13 - which may provide a new avenue to prevent the build up of alpha-synuclein in brain cells.
A US study has found that people with Attention-Deficit Hyperactivity Disorder (ADHD) may have an increased risk of developing Parkinson's.
In August 2018, Kyle Alexander was appointed by co-option to the Board of Trustees, bringing a Northern Ireland presence to the board.
Researchers in Israel have made positive steps towards a simple diagnostic test for Parkinson's.
New research highlights importance of LRRK2 as a pivotal player in all kinds of Parkinson's, not just genetic forms.
The government have announced a relaxation of the laws governing access to cannabis-based medicines. This will give doctors the ability to prescribe them.
Researchers in America have developed an experimental drug, similar to compounds used to treat diabetes, that slows the progression of Parkinson's in a mouse model of the condition.
Researchers have discovered that nicotinamide riboside, a form of vitamin B3, may boost energy in nerve cells and help prevent them being lost in Parkinson's.